Cargando…
The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus?
Abscisic acid (ABA), long known as a plant stress hormone, is present and functionally active in organisms other than those pertaining to the land plant kingdom, including cyanobacteria, fungi, algae, protozoan parasites, lower Metazoa, and mammals. The ancient, cross-kingdom role of this stress hor...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863406/ https://www.ncbi.nlm.nih.gov/pubmed/36674711 http://dx.doi.org/10.3390/ijms24021199 |
_version_ | 1784875326298390528 |
---|---|
author | Spinelli, Sonia Magnone, Mirko Guida, Lucrezia Sturla, Laura Zocchi, Elena |
author_facet | Spinelli, Sonia Magnone, Mirko Guida, Lucrezia Sturla, Laura Zocchi, Elena |
author_sort | Spinelli, Sonia |
collection | PubMed |
description | Abscisic acid (ABA), long known as a plant stress hormone, is present and functionally active in organisms other than those pertaining to the land plant kingdom, including cyanobacteria, fungi, algae, protozoan parasites, lower Metazoa, and mammals. The ancient, cross-kingdom role of this stress hormone allows ABA and its signaling pathway to control cell responses to environmental stimuli in diverse organisms such as marine sponges, higher plants, and humans. Recent advances in our knowledge about the physiological role of ABA and of its mammalian receptors in the control of energy metabolism and mitochondrial function in myocytes, adipocytes, and neuronal cells allow us to foresee therapeutic applications for ABA in the fields of pre-diabetes, diabetes, and cardio- and neuro-protection. Vegetal extracts titrated in their ABA content have shown both efficacy and tolerability in preliminary clinical studies. As the prevalence of glucose intolerance, diabetes, and cardiovascular and neurodegenerative diseases is steadily increasing in both industrialized and rapidly developing countries, new and cost-efficient therapeutics to combat these ailments are much needed to ensure disease-free aging for the current and future working generations. |
format | Online Article Text |
id | pubmed-9863406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98634062023-01-22 The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus? Spinelli, Sonia Magnone, Mirko Guida, Lucrezia Sturla, Laura Zocchi, Elena Int J Mol Sci Review Abscisic acid (ABA), long known as a plant stress hormone, is present and functionally active in organisms other than those pertaining to the land plant kingdom, including cyanobacteria, fungi, algae, protozoan parasites, lower Metazoa, and mammals. The ancient, cross-kingdom role of this stress hormone allows ABA and its signaling pathway to control cell responses to environmental stimuli in diverse organisms such as marine sponges, higher plants, and humans. Recent advances in our knowledge about the physiological role of ABA and of its mammalian receptors in the control of energy metabolism and mitochondrial function in myocytes, adipocytes, and neuronal cells allow us to foresee therapeutic applications for ABA in the fields of pre-diabetes, diabetes, and cardio- and neuro-protection. Vegetal extracts titrated in their ABA content have shown both efficacy and tolerability in preliminary clinical studies. As the prevalence of glucose intolerance, diabetes, and cardiovascular and neurodegenerative diseases is steadily increasing in both industrialized and rapidly developing countries, new and cost-efficient therapeutics to combat these ailments are much needed to ensure disease-free aging for the current and future working generations. MDPI 2023-01-07 /pmc/articles/PMC9863406/ /pubmed/36674711 http://dx.doi.org/10.3390/ijms24021199 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Spinelli, Sonia Magnone, Mirko Guida, Lucrezia Sturla, Laura Zocchi, Elena The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus? |
title | The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus? |
title_full | The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus? |
title_fullStr | The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus? |
title_full_unstemmed | The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus? |
title_short | The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus? |
title_sort | aba/lancl hormone/receptor system in the control of glycemia, of cardiomyocyte energy metabolism, and in neuroprotection: a new ally in the treatment of diabetes mellitus? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863406/ https://www.ncbi.nlm.nih.gov/pubmed/36674711 http://dx.doi.org/10.3390/ijms24021199 |
work_keys_str_mv | AT spinellisonia theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT magnonemirko theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT guidalucrezia theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT sturlalaura theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT zocchielena theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT spinellisonia abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT magnonemirko abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT guidalucrezia abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT sturlalaura abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus AT zocchielena abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus |